MicroRNA let-7c contributes to paclitaxel resistance via aurora-b in endometrial serous carcinoma

Izumi Sato, Masumi Ishibashi, Hideki Tokunaga, Shogo Shigeta, Shoko Sakurada, Muneaki Shimada, Satoru Nagase, Yoh Watanabe, Nobuo Yaegashi

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The incidence of endometrial cancer has rapidly risen over recent years. Paclitaxel, a key drug for endometrial cancer treatment, inhibits microtubule depolymerization and induces apoptosis in cancer cells. Endometrial serous carcinoma (ESC) accounts for < 10% of all endometrial carcinomas, but its aggressive nature makes it responsible for close to 40% of cancer deaths. Thus, novel therapeutic targets are required for ESC. To identify microRNAs that promote paclitaxel resistance, we established two paclitaxel-resistant cell lines from USPC1 human ESC cells by exposing paclitaxel to parental cells for 12 weeks. Paclitaxel concentrations were increased every 2 weeks, and after 12 weeks of paclitaxel exposure, two replicate paclitaxel-resistant cell lines were established (USPC1-PTSR1 and USPC1-PTXR2). The microarray analysis was performed using USPC1 cells and USPC1-PTXR1 cells, and eight candidate microRNAs were thus selected as potential mediators of paclitaxel sensitivity. Among these candidate microRNAs, let-7c precursor treatment of paclitaxel-resistant USPC1-PTXR1 cells caused the greatest increase in paclitaxel-mediated cytotoxicity. Let-7c inhibition conversely decreased paclitaxel-induced apoptosis. It is known that let-7a microRNA, a member of the let-7 family, inhibits growth of endometrial carcinoma cells targeting Aurora-B that controls progression through each phase of mitosis. We thus studied whether let-7c mediates Aurora-B expression in ESC cells. The expression levels of Aurora-B mRNA and protein were higher in USPC-PTXR1 cells compared with USPC1 cells. Let-7c inhibition increased Aurora-B expression in USPC1 cells but decreased Aurora-B expression in USPC1-PTXR1 cells. These results indicate that let-7c mediates paclitaxel resistance via inhibition of Aurora-B expression in ESC cells.

Original languageEnglish
Pages (from-to)263-272
Number of pages10
JournalTohoku Journal of Experimental Medicine
Volume251
Issue number4
DOIs
Publication statusPublished - 2020 Aug

Keywords

  • Aurora-B
  • Endometrial serous carcinoma
  • Let-7c
  • MicroRNA
  • Paclitaxel

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'MicroRNA let-7c contributes to paclitaxel resistance via aurora-b in endometrial serous carcinoma'. Together they form a unique fingerprint.

Cite this